Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | Director | September 09, 2026 | September 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date September 09, 2026 · Filed September 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units - 11SEC Table II · derivative / convertible security | Direct | 1,774 |
Reported balance
After 2026-09-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-09 · Grant · Acquired 1,774 · Balance 1,774 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2: RSUs that vest September 9, 2027 F3: Not Applicable |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vest September 9, 2027
F3: Not Applicable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2021 Filed Feb 1, 2021 23:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,250 | $277.67 | $347,087.50 |
DisclosureSEC source: 0001228924-21-000005 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,208 F1 · kind: Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on 8-17-20 Read SEC document |
| January 04, 2021 Filed Jan 4, 2021 22:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,250 | $280.82 | $351,025.00 |
DisclosureSEC source: 0001228924-21-000001 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,458 F1 · kind: Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on 8-17-20 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 00:36 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,250 | $275.22 | $344,025.00 |
DisclosureSEC source: 0001228924-20-000040 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,708 F1 · kind: Sale reported on Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8-17-2020 Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 16:17 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 3 · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000035 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 477 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vested on November 15, 2020 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 16:17 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 5 · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000035 · primary_doc.xml · derivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308 Underlying: Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 16:17 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000035 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Represents common stock from TSUs that vested on November 15, 2020 Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 17:24 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,250 | $272.36 | $340,450.00 |
DisclosureSEC source: 0001437749-20-023560 · rdgdoc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,481 Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 22:13 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 4 · Derivative | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000010 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310 Underlying: Common Stock · 310 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F4 · shares: Represents RSUs granted for the conversion of cash compensation for Board of Director services for the next 12 months. F5 · derivative.exercise_date: Restricted Stock Units that cliff vest on June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 22:13 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000010 · primary_doc.xml · derivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 22:13 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000010 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherIncentive Stock Option · Derivative | 799 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · derivative · entry 9 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,988 Underlying: Common Stock · 799 shares Expires 2023-04-01 F3 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 4-1-15 grant date Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherIncentive Stock Option · Derivative | 785 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · derivative · entry 8 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,787 Underlying: Common Stock · 785 shares Expires 2022-04-01 F2 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/14 grant date Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 208 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · derivative · entry 7 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,572 Underlying: Common Stock · 208 shares Expires 2022-04-01 F2 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/01/14 grant date Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,494 | $0.00 Strike: $51.85 | $0.00 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · derivative · entry 6 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,780 Underlying: Common Stock · 1,494 shares Expires 2023-04-01 F1 · derivative.exercise_date: 1/4 exercisable on each anniverary date of the 04/01/13 grant Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 799 | $70.56 | $56,377.44 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · nonDerivative · entry 5 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 785 | $89.70 | $70,414.50 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · nonDerivative · entry 4 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,702 | $256.02 | $435,746.04 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · nonDerivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,347 Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 208 | $89.70 | $18,657.60 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 00:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,494 | $51.85 | $77,463.90 |
DisclosureSEC source: 0001228924-20-000006 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Othernon Qualified Stock Option · Derivative | 970 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · derivative · entry 10 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,274 Underlying: Common Stock · 970 shares Expires 2022-04-01 F3 · derivative.exercise_date: 1/7 exercisable each anniversary date of the 4-1-14 grant date Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 100 | $0.00 Strike: $51.85 | $0.00 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · derivative · entry 9 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,244 Underlying: Common Stock · 100 shares Expires 2023-04-01 F2 · derivative.exercise_date: 25% exercisable on each anniversary date of the 4-1-13 grant date Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,070 | $263.39 | $281,827.30 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · nonDerivative · entry 6 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,347 Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 970 | $89.70 | $87,009.00 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · nonDerivative · entry 5 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 100 | $51.85 | $5,185.00 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · nonDerivative · entry 4 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 2,206 | $0.00 Strike: $51.85 | $0.00 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · derivative · entry 8 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,344 Underlying: Common Stock · 2,206 shares Expires 2023-04-01 F2 · derivative.exercise_date: 25% exercisable on each anniversary date of the 4-1-13 grant date Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 6,000 | $0.00 Strike: $50.50 | $0.00 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · derivative · entry 7 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,550 Underlying: Common Stock · 6,000 shares Expires 2022-04-02 F1 · derivative.exercise_date: 25% Exercisable on each anniversary of the 4-2-13 grant date Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 8,206 | $267.09 | $2,191,740.54 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · nonDerivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,347 Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 2,206 | $51.85 | $114,381.10 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 23:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 6,000 | $50.50 | $303,000.00 |
DisclosureSEC source: 0001228924-20-000005 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 20:30 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 3 · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000046 · primary_doc.xml · derivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477 Underlying: Common Stock · 477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest on November 15, 2020 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 07, 2019 Filed Nov 7, 2019 16:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000039 · primary_doc.xml · derivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vested on November 7, 2019 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 07, 2019 Filed Nov 7, 2019 16:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000039 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Represents stock from a RSUs that vested on November 7, 2019. No shares were sold by the reporting person in connection with this transaction. Read SEC document |
| September 06, 2019 Filed Apr 10, 2020 20:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 4,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000009 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,701 Read SEC document |
| September 06, 2019 Filed Apr 10, 2020 20:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GiftCommon Stock | 4,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000009 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,301 Read SEC document |
| June 15, 2019 Filed Jun 18, 2019 20:44 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000032 · primary_doc.xml · derivative · entry 4 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2019 Filed Jun 18, 2019 20:44 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 11 | $202.39 | $2,226.29 |
DisclosureSEC source: 0001228924-19-000032 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,197 Read SEC document |
| June 15, 2019 Filed Jun 18, 2019 20:44 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000032 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 28, 2018 22:48 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-18-000035 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,448 F1 · shares: Restricted Stock Units that vest on November 7,2019 and convert into common stock on a one-for-one basis Read SEC document |
| November 07, 2018 Filed Jun 18, 2019 20:44 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 2 · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000032 · primary_doc.xml · derivative · entry 5 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: Restricted Stock Units that vest on November 7, 2019 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 19:57 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 8,800 | $0.00 Strike: $29.20 | $0.00 |
DisclosureSEC source: 0001228924-18-000021 · primary_doc.xml · derivative · entry 5 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,550 Underlying: Common Stock · 8,800 shares Expires 2021-04-01 F2 · derivative.exercise_date: 25% Exercisable on each anniversary of the 4/01/11 grant date Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 19:57 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 3,200 | $0.00 Strike: $25.56 | $0.00 |
DisclosureSEC source: 0001228924-18-000021 · primary_doc.xml · derivative · entry 4 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,350 Underlying: Common Stock · 3,200 shares Expires 2020-04-01 F1 · derivative.exercise_date: 25% Exercisable on each anniversary of the 4/01/10 grant date Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 19:57 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 12,000 | $197.02 | $2,364,240.00 |
DisclosureSEC source: 0001228924-18-000021 · primary_doc.xml · nonDerivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,298 Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 19:57 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 8,800 | $29.20 | $256,960.00 |
DisclosureSEC source: 0001228924-18-000021 · primary_doc.xml · nonDerivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 19:57 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 3,200 | $25.56 | $81,792.00 |
DisclosureSEC source: 0001228924-18-000021 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 17:30 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 450 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001228924-18-000012 · primary_doc.xml · derivative · entry 2 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,550 Underlying: Common Stock · 450 shares Expires 2024-04-02 F1 · derivative.exercise_date: 1/5 exercisable on each of the first five anniversary dates Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 17:30 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-18-000012 · primary_doc.xml · nonDerivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,298 F2 · shares: Restricted Stock Award that vests 1/5 on June 15, 2019 and 1/5 on the next four anniversary dates thereafter Read SEC document |
| April 02, 2018 Filed Jun 18, 2019 20:44 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 1 · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000032 · primary_doc.xml · derivative · entry 3 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| March 26, 2018 Filed Mar 26, 2018 14:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon-qualified stock options · Derivative | 4,500 | $0.00 Strike: $70.56 | $0.00 |
DisclosureSEC source: 0001228924-18-000007 · primary_doc.xml · derivative · entry 1 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,100 Underlying: Common Stock · 4,500 shares Expires 2021-04-01 F1 · shares: Performance based non-qualified stock options issued April 1, 2015 that did not vest based on stated performance criteria. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 2,123 | $0.00 Strike: $25.56 | $0.00 |
DisclosureSEC source: 0001228924-18-000003 · primary_doc.xml · derivative · entry 8 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,600 Underlying: Common Stock · 2,123 shares Expires 2020-04-01 Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 2,123 | $138.00 | $292,974.00 |
DisclosureSEC source: 0001228924-18-000003 · primary_doc.xml · nonDerivative · entry 5 Sullivan John James · CIK 0001305784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,148 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.